Latest Form 4 insider transactions
NASDAQ
PRAA
Pra Group INCRichard Owen James, President - PRA Group Europe of Pra Group Inc, reported a transaction in 1,844 shares of common stock on August 15, 2026.
NASDAQ
FOXA
Fox CORPSteven Tomsic, Chief Financial Officer of Fox Corp, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Thomas Desrosier, See Remarks of Seres Therapeutics, Inc., sold 82 shares of common stock on August 15, 2026 for $4.55 per share.
NASDAQ
FOXA
Fox CORPAdam G. Ciongoli, Chief Legal and Policy Officer of Fox Corp, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
FOXA
Fox CORPJohn Nallen, President, COO of Fox Corp, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
FOXA
Fox CORPLachlan K Murdoch, Executive Chair, CEO and a Director of Fox Corp, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Esam Elashmawi, SVP, Strategy and Marketing of Lattice Semiconductor Corp, sold 15,742 shares of common stock on August 16, 2026.
NASDAQ
FOXA
Fox CORPKeith Rupert Murdoch, Chairman Emeritus of Fox Corp, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Hoose Kyri K. Van, SVP, CFO of Dermata Therapeutics, Inc., reported multiple transactions in common stock on August 16, 2026.
NASDAQ
Regina Margaret Graul, See Remarks and a Director of Cyclerion Therapeutics, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Justyn Feldman, a Director of Douglas Elliman Inc., received 74,627 shares of common stock on August 14, 2026.
NASDAQ
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, Inc., sold 3,040 shares of common stock on August 17, 2026 for $23.23 per share.
NASDAQ
FRMI
Fermi LLCForm 4: Fermi CEO Receives Stock Grant
Lee A Mcintire, Chief Executive Officer and a Director of Fermi LLC, received 468,750 shares of common stock on August 14, 2026.
NYSE
Todd Mcelhatton, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.
NASDAQ
AMPL
Amplitude, INCCurtis Liu, Chief Technology Officer, a Director and 10% owner of Amplitude, Inc., reported a transaction in 53,878 shares of common stock on August 17, 2026.
NASDAQ
AMPL
Amplitude, INCSpenser Skates, CEO and President, a Director and 10% owner of Amplitude, Inc., reported a transaction in 52,369 shares of common stock on August 17, 2026.
NASDAQ
T. Luke Longhofer, EVP - Chief Credit Officer of First Financial Bankshares Inc, reported multiple transactions in common stock on August 14, 2026.
NYSE
Kimberly K. Nelson, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.
NASDAQ
AMPL
Amplitude, INCNathaniel Glenn Crook, Chief Commercial Officer of Amplitude, Inc., reported a transaction in 109,368 shares of common stock on August 17, 2026.
NYSE
Daniel J Gray, President, GIS of DXC Technology Co, received 100,310 shares of common stock on August 17, 2026.
NYSE
Ramanathan Venkataraman, EVP, CES of DXC Technology Co, reported a transaction in 14,247 shares of common stock on August 14, 2026.
NYSE
CVX
Chevron CORPForm 4: Chevron CEO Sells Shares
Michael K Wirth, Chairman and CEO and a Director of Chevron Corp, sold 317,100 shares of common stock on August 14, 2026.
NASDAQ
Chad M. Smith, Pres & COO, Better Mortgage of Better Home & Finance Holding Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Steven D Macicek, a Director of American Vanguard Corp, purchased 19,000 shares of common stock on August 17, 2026 for $2.09 per share.
NASDAQ
AMPL
Amplitude, INCAndrew Casey, Chief Financial Officer of Amplitude, Inc., reported a transaction in 72,814 shares of common stock on August 17, 2026.
NASDAQ
CPRT
Copart INCJane Pocock, President of Copart Inc, reported multiple transactions in common stock on August 16, 2026.
NASDAQ
TECH
Bio-techne CORPKim Kelderman, Chief Executive Officer and a Director of BIO-TECHNE Corp, reported multiple transactions in common stock on August 15, 2026.
NYSE
Shriram Revankar, SVP, Advanced Technology Group of Dolby Laboratories, Inc., sold 3,000 shares of common stock on August 14, 2026 for $62.71 per share.
NYSE
NGVT
Ingevity CORPForm 4: Ingevity CEO Sells Shares
David H Li, President & CEO and a Director of Ingevity Corp, sold 10,092 shares of common stock on August 14, 2026.
NYSE
MTZ
Mastec INCManuel Benito Miranda, a Director of Mastec Inc, received 152 shares of common stock on August 14, 2026.